Cargando…

Therapeutic Effects of Fibroblast Growth Factor-21 on Diabetic Nephropathy and the Possible Mechanism in Type 1 Diabetes Mellitus Mice

BACKGROUND: Fibroblast growth factor 21 (FGF21) has been only reported to prevent type 1 diabetic nephropathy (DN) in the streptozotocin-induced type 1 diabetes mellitus (T1DM) mouse model. However, the FVB (Cg)-Tg (Cryaa-Tag, Ins2-CALM1) 26OVE/PneJ (OVE26) transgenic mouse is a widely recommended m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weng, Wenya, Ge, Tingwen, Wang, Yi, He, Lulu, Liu, Tinghao, Wang, Wanning, Zheng, Zongyu, Yu, Lechu, Zhang, Chi, Lu, Xuemian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453991/ https://www.ncbi.nlm.nih.gov/pubmed/32431116 http://dx.doi.org/10.4093/dmj.2019.0089

Ejemplares similares

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
por: Lin, Sundong, et al.
Publicado: (2020)

Zinc Supplementation Prevented Type 2 Diabetes-Induced Liver Injury Mediated by the Nrf2-MT Antioxidative Pathway
por: Yu, Lechu, et al.
Publicado: (2021)

Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
por: Yang, Hong, et al.
Publicado: (2018)

The role of FGF21 in type 1 diabetes and its complications
por: Zhang, Jian, et al.
Publicado: (2018)

Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
por: Zhang, Chi, et al.
Publicado: (2013)

Relationships of the Trace Elements Zinc and Magnesium With Diabetic Nephropathy-Associated Renal Functional Damage in Patients With Type 2 Diabetes Mellitus
por: Feng, Jianan, et al.
Publicado: (2021)

Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients
por: Corbee, Ronald J., et al.
Publicado: (2023)

Role of sirtuin-1 in diabetic nephropathy
por: Wang, Wanning, et al.
Publicado: (2019)

Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice
por: Yan, Xiaoqing, et al.
Publicado: (2015)

Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
por: Gawlik, Katarzyna, et al.
Publicado: (2023)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

Role of sex hormones in diabetic nephropathy
por: Liu, Jiahui, et al.
Publicado: (2023)

Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis
por: Zheng, Zongyu, et al.
Publicado: (2019)

The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus
por: Jia, Xiaojiao, et al.
Publicado: (2022)

MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies
por: Dhas, Yogita, et al.
Publicado: (2023)

The Role of Akt2 in the Protective Effect of Fenofibrate against Diabetic Nephropathy
por: Cheng, Yanli, et al.
Publicado: (2020)

Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications
por: Goycheva, Petya, et al.
Publicado: (2023)

The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
por: Deng, Junyu, et al.
Publicado: (2021)

MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy
por: Liu, Shuijiao, et al.
Publicado: (2022)

The diagnostic model for early detection of gestational diabetes mellitus and gestational diabetic nephropathy
por: Chong, Huimin, et al.
Publicado: (2022)

Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus
por: Taniguchi, Hirokazu, et al.
Publicado: (2022)

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis
por: Kanasaki, Keizo, et al.
Publicado: (2013)

Effect of edaravone in diabetes mellitus-induced nephropathy in rats
por: Varatharajan, Rajavel, et al.
Publicado: (2016)

Experimental model of nephropathy associated with diabetes mellitus in mice
por: Silva, Pâmela Henrique, et al.
Publicado: (2023)

Assessment of fibroblast growth factor 21 in children with type 1 diabetes mellitus in relation to microvascular complications
por: Tantawy, Nermien M., et al.
Publicado: (2023)

Idiopathic membranous nephropathy in patients with diabetes mellitus: a diagnostic and therapeutic quandary!
por: Bhadauria, Dharmendra, et al.
Publicado: (2018)

Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism
por: Weng, Hua-Chun, et al.
Publicado: (2021)

Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus
por: Wheelock, Kevin M., et al.
Publicado: (2017)

Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?
por: Afifa, Koubaa, et al.
Publicado: (2016)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

L-Lysine Ameliorates Diabetic Nephropathy in Rats with Streptozotocin-Induced Diabetes Mellitus
por: Jozi, Faezeh, et al.
Publicado: (2022)

Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China
por: Yang, Hong, et al.
Publicado: (2014)

Comparative analysis of diabetic nephropathy and non-diabetic nephropathy disease
por: Chen, Qiuxiang, et al.
Publicado: (2017)

The association between the red cell distribution width and diabetic nephropathy in patients with type-2 diabetes mellitus
por: Zhang, Junlin, et al.
Publicado: (2018)

Fibroblast Growth Factor 21 and Its Association With Oxidative Stress and Lipid Profile in Type 2 Diabetes Mellitus
por: Aleem, Mudassar, et al.
Publicado: (2021)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

Therapeutic Advances in Diabetic Nephropathy
por: Sawaf, Hanny, et al.
Publicado: (2022)

Evaluation of the Therapeutic Effects of Protocatechuic Aldehyde in Diabetic Nephropathy
por: Chang, Yu-Teng, et al.
Publicado: (2021)

Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease
por: Lin, Zhenzhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mee3hi2g9bva55lsqmka1j7m45